1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms)
Abstract
Compound of formula I: or a pharmaceutically acceptable salt thereof; wherein: the dotted line between Y and Z represents an optional double bond; the dotted line between the two R4 groups represents an optional heterocyclic ring of 4 to 6 ring atoms that may be formed between the two R4 groups, together with the nitrogen through which they are attached; Y is N, CR6 or C = O; Z is N, NR7, CR5 or C (R5) 2; R1 is, independently at each occurrence, alkyl, alkoxy, halo, CF3, OCF3, arylalkyloxy substituted with 0 to 3 R11, aryloxy substituted with 0 to 3 R11, aryl substituted with 0 to 3 R11, heteroaryl substituted with 0 to 3 R11, hydroxy, alkanoyloxy, nitro, nitrile, alkenyl, alkynyl, alkyl sulfoxide, dimethyl phenyl substituted with 0 to 3 R11, alkylsulfone, phenylsulfone substituted with 0 to 3 R11, alkylsulfonamide, phenylsulfonamide substituted with 0 to 3 R11, heteroaryloxy substituted with 0 to 3 R11, I heteroarilmetiloxi substituted with 0 to 3 R11, alkylamido, or arylamido substituted con0 I to 3 R11; or two adjacent R1 also represent methylenedioxy; R2 is aryl substituted with 0 to 3 R1, or heteroaryl substituted with 0 to 3 R1; R3 is H or C1-C4 alkyl; R4 is, independently each occurrence, H, C1-C4 alkyl, arylalkyl, heteroarylmethyl, cycloheptylmethyl, cyclohexylmethyl, cyclopentylmethyl or cyclobutylmethyl, or both R4 groups together with the nitrogen through which they are attached form a heterocyclic ring of 4 to 6 atoms ring, wherein one carbon may be optionally substituted with N, O, S or SO2, and wherein any ring carbon atom or N atom a further optionally substituted with alkyl may C1-C4 alkyl, F or CF3; R5 is, independently each occurrence, H, C1-C4 alkyl, aryl substituted with 0 to 3 R1, or cyano; or two R5 when present, form a carbocyclic ring of 3 to 7 carbons; R6 is H, C1-C4 alkyl or cyano; R7 is H, C1-C6 alkyl, C3-C6 cycloalkyl or aryl substituted with 0 to 3 R1; R8 is H or C1-C4 alkyl; R9 is H or C1-C4 alkyl; R10 is, independently at each occurrence, H or C1-C4 alkyl; or R10 and R4 together with the nitrogen to which R4 is attached form a nitrogen containing ring of 3 to 6 carbon atoms; n is an integer from 0 to 4; x is an integer from 1 to 2; and R11 is alkyl, alkoxy, halo, CF3, OCF3, hydroxy, alkanoyloxy, nitro, nitrile, alkenyl, alkynyl, alkyl sulfoxide, alkylsulfone, alkylsulfonamide, or alkylamido; or two adjacent R11 also represent methylenedioxy; wherein 1 to 3 carbon atoms in ring A may optionally be substituted with N.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
30 members in 25 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 55765104 | United States of America | P | |
| 56986304 | United States of America | P | |
| 9188505 | United States of America | A |
Members30
| Document | Office | Kind | |
|---|---|---|---|
| US2005222148A1 | United States of America | A1 | |
| AU2005230900A1 | Australia | A1 | |
| CA2560967A1 | Canada | A1 | |
| WO2005097744A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW200536532A | Taiwan Province of China | A | |
| PA8628001A1 | Panama | A1 | |
| AR048675A1 | Argentina | A1 | |
| PE20060288A1 | Peru | A1 | |
| SV2006002068A | El Salvador | A | |
| ECSP066899A | Ecuador | A | |
| NO20064892L | Norway | L | |
| EP1732887A1 | European Patent Office (EPO) | A1 | |
| KR20060134186A | Republic of Korea | A | |
| IL178185D0 | Israel | D0 | |
| CN1960973A | China | A | |
| CR8639A | Costa Rica | A | |
| BRPI0509390A | Brazil | A | |
| JP2007531751A | Japan | A | |
| EP1732887B1 | European Patent Office (EPO) | B1 | |
| AT383337TThis record | Austria | T | |
| DE602005004268D1 | Germany | D1 | |
| DK1732887T3 | Denmark | T3 | |
| RU2006134012A | Russian Federation | A | |
| ES2299025T3 | Spain | T3 | |
| PL1732887T3 | Poland | T3 | |
| ZA200608134B | South Africa | B | |
| DE602005004268T2 | Germany | T2 | |
| US2009093469A1 | United States of America | A1 | |
| US7517899B2 | United States of America | B2 | |
| US2009099164A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 5730271
Titles2
- German
- 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1- PHENYLPROPAN-2-OLDERIVATE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN DER NOREPINEPHRIN- (NE-) UND DER SEROTONIN-(5-HT-) AKTIVITÄT UND DER MONOAMINWIEDERAUFNAHME ZUR BEHANDLUNG VON VASOMOTORISCHEN SYMPTOMEN (VMS)
- English
- 1- (1H-INDOL-1-YL) -3- (4-METHYLPIPERAZIN-1-YL) -1-PHENYLPROPAN-2-OLDERIVATE AND RELATED COMPOUNDS AS MODULATORS OF NOREPINEPHRIN- (NE-) AND SEROTONIN- (5- HT-) ACTIVITY AND MONOAMIN RECOVERY FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS)
Classification
- CPC, 20
- C07D209/08
- C07D209/14
- A61P1/00
- C07D209/30
- A61P13/00
- C07D209/42
- A61P13/02
- C07D235/06
- A61P15/00
- C07D241/42
- A61P15/10
- C07D265/36
- A61P25/00
- C07D471/04
- A61P25/22
- A61P25/24
- A61P29/00
- A61P43/00
- C07D413/06
- C07D401/06
- IPC, 8
- C07D209 08
- A61K31 4045
- C07D209 30
- C07D209 42
- C07D235 06
- C07D241 42
- C07D265 36
- C07D471 04